Investment Firm
Overview
Glympse Bio is a biotechnology company that transforms disease detection and predict treatment response.
Dec 01, 2015
Seed
Highlights
N/A
Location
Social
N/A
Investor Lead
N/A
Participant Investors
2
Investor Name |
---|
Biocon |
Aspect Ventures |
Glympse Bio raised $6600000 on 2015-12-01 in Seed Round
Glympse Bio is a biotechnology company that transforms disease detection and predict treatment response.
Company Funding History
4
Announcment Date | Transaction Name | Number Of Investors | Lead Investor | Money Raised |
---|---|---|---|---|
Oct 09, 2018 | Series A - Glympse Bio | 9 | - | 22.0M |
Dec 01, 2015 | Seed Round - Glympse Bio | 2 | - | 6.6M |
Jul 15, 2020 | Series B - Glympse Bio | 12 | - | 46.7M |
Dec 17, 2021 | Venture Round - Glympse Bio | - | 18.0M |
Recent Activity
There is no recent news or activity for this profile.